TELA Bio (TELA) Deferred Taxes (2025)

TELA Bio (TELA) recorded quarterly Deferred Taxes of $59000.0 in Q4 2025, up 78.79% quarter-over-quarter from $33000.0 in Q2 2025.

TELA Bio (TELA) Deferred Taxes (2025) Analysis & Trends

TELA Bio's Deferred Taxes history runs 1 years deep, the most recent figure standing at $59000.0 for Q4 2025.

In Q4 2025, Deferred Taxes changed N/A year-over-year to $59000.0; the TTM figure through Dec 2025 stood at $144000.0 (changed N/A YoY), while the FY2025 annual figure was $144000.0, up 200.0% from the prior year.
Deferred Taxes was $59000.0 for Q4 2025 at TELA Bio, up from $33000.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $59000.0 in Q4 2025 to a low of $33000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-33.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-101.00 Mn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-351.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-9.40 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	300,000.00
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-16.70 Mn
10	TELA Bio	48.23 Mn	8.69 Mn	12.52 Mn	-

Download Data